|
Bupropion as a Smoking Cessation Aid in Alcoholics Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Bupropion as a Smoking Cessation Aid in Alcoholics conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Bupropion as a Smoking Cessation Aid in Alcoholics Clinical research trials and Bupropion as a Smoking Cessation Aid in Alcoholics healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Bupropion as a Smoking Cessation Aid in Alcoholics. Bupropion as a Smoking Cessation Aid in Alcoholics Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Bupropion as a Smoking Cessation Aid in Alcoholics clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Bupropion as a Smoking Cessation Aid in Alcoholics condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "B" Clinical Trials Conditions > Bupropion as a Smoking Cessation Aid in Alcoholics  Bupropion as a Smoking Cessation Aid in Alcoholics
Bupropion as a Smoking Cessation Aid in Alcoholics
For Condition: Smoking,Alcoholism
Status: Recruiting
Sponsor(s): National Institute on Alcohol Abuse and Alcoholism (NIAAA) ,
Synopsis: The purpose of this study is to test the use of time-released bupropion (Wellbutrin) in patients receiving treatment for alcohol abuse/dependence as an aid to stop smoking. Patients will receive either a time-released bupropion or placebo. Both groups will receive nicotine replacement therapy during the 9 week study. A final followup assessment will be conducted 6 months from the start of treatment.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Safety/Efficacy Study
Minimum Age/Maximum Age: 25 Years/75 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Currently a patient in the Omaha VA Medical Center, Substance Abuse Treatment Center (SATC) or at Catholic Charities Campus for Hope. - Have a diagnosis of alcohol abuse or alcohol dependence. - Smoke 20 or more cigarettes/day (may also smoke pipes/cigars). - Be interested in quitting smoking. - Provide name, addresses, and phone numbers of at least two individuals who can provide information on their alcohol, nicotine, and other drug use during the follow-up period. - If female, patient must a) be of non-childbearing potential, b) have a negative pregnancy test, c) sign a document stating they do not plan on becoming pregnant during the study. - Agree to sign informed consent. - Able to read and understand study-related forms and procedures. Exclusion Criteria: - Advanced cardiac, pulmonary, renal, or liver disease. - History of seizures. - History of brain tumor or significant head trauma. - History of bulimia or anorexia nervosa. - Current major depressive disorder or past history of panic disorders, schizophrenia, or bipolar affective disorder. - Using psychoactive drugs. - Receiving treatment with medications that lower seizure thresholds. - Use of an investigational drug in any study in the past four weeks. - Currently using any asthma medication. - Used time-released bupropion in the past 12 months. - Currently using any other treatments to stop smoking.
Total Enrollment: 200
Location and Contact Information:
VA/Nebraska/Western Iowa Health Care System *Recruiting*
Omaha, Nebraska, 68105
United States
Recruiting Dr. Grant 402-977-5647
Additional Information:
Study ID Numbers: NIAAAGRA13689;
Study Start Date:
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00044434
Other Smoking Studies:
1. Tobacco Dependence in Alcoholism Treatment (nicotine patch/naltrexone)
2. Facilitating Implementation of the U.S. Public Health Service Smoking Cessation Guideline
3. Behavioral Counseling for Alcohol Dependent Smokers (nicotine patch)
4. Ultrasound and motivational enhancement for prenatal smoking cessation
5. Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch)
Related Studies:
Other Smoking Clinical Trials
Other Nebraska Clinical Trials
Other Omaha Clinical Trials
Bupropion as a Smoking Cessation Aid in Alcoholics
|
|
|
|
|
|
|
|
